SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-028107
Filing Date
2012-05-11
Accepted
2012-05-11 16:53:09
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v311796_10q.htm 10-Q 737136
2 EXHIBIT 10.1 v311796_ex10-1.htm EX-10.1 5432
3 EXHIBIT 31.1 v311796_ex31-1.htm EX-31.1 6938
4 EXHIBIT 31.2 v311796_ex31-2.htm EX-31.2 6870
5 EXHIBIT 32.1 v311796_ex32-1.htm EX-32.1 3073
6 EXHIBIT 32.2 v311796_ex32-2.htm EX-32.2 3060
  Complete submission text file 0001144204-12-028107.txt   3179035

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bcli-20120331.xml EX-101.INS 504607
8 XBRL TAXONOMY EXTENSION SCHEMA bcli-20120331.xsd EX-101.SCH 31107
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20120331_cal.xml EX-101.CAL 23186
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20120331_def.xml EX-101.DEF 90459
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20120331_lab.xml EX-101.LAB 201113
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20120331_pre.xml EX-101.PRE 112474
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54365 | Film No.: 12835310
SIC: 2836 Biological Products, (No Diagnostic Substances)